Lysine Biotech Logo

LYSINE BIOTECH PRIVATE LIMITED
 Product development and Manufacture of drugs, biomarkers and vaccines from Protein and DNA
 CIN:U74999TN2018PTC122879
 

S.NoLBPL drugs delivery (IND) Product DevelopmentPreclinical TestingCommercial License (IP)
1LBPL101 Kilirag-1 drug for treating type 2 diabetes in obese
100% Complete
2025
2LBPL102 Ktictide-NPPA Congestive Heart Failure (IND)
100% Complete
2025
3LBPL103 Kpondin1 (Spondin-1)- Alzheimer's (IND)
100% Complete
2025
-->
S.NoLBPL Business model original pipelines CAR T-cellsResearch and DevelopmentPreclinical Testing Clinical and Commercial License (IP)
1LBPL201 Product Prime CAR T-cell (Autologous) Target--
100% Complete
2025
1LBPL202 Product Prime CAR T-cell (Allogeneic) Target--
100% Complete
2026
-->
S.NoLBPL Biosimliars mAbs PipelineProduct DevelopmentPreclinical TestingCommercial License (IP)
1LBPL301 Kembrolizumab (Pembrolizumab)
100% Complete
2024
2LBPL302 Kculizumab (Eculizumab)
100% Complete
2024
3LBPL303 Keriparatide (Teriparatide)
100% Complete
2024
4LBPL304 Kdalimumab (Adalimumab)
100% Complete
2024
5LBPL305 Kanibizumab (Ranibizumab)
100% Complete
2024
6LBPL306 Kegfilgrastim (Pegfilgrastim)
100% Complete
2024
7LBPL307 Kituximab (Rituximab)
100% Complete
2024
8LBPL308 Kolimumab (Golimumab)
100% Complete
2024
9LBPL309 Krastuzumab (Trastuzumab)
100% Complete
2024
10LBPL310 Insulin Klargine (insulin glargine)
100% Complete
2024
-->
S.NoLBPL Biobetters mAbs PipelineProduct DevelopmentPreclinical TestingCommercial License (IP)
1LBPL401 Kenralizumab (Benralizumab)
100% Complete
2025
2LBPL402 Kaplacizumb (Caplacizumab)
100% Complete
2025
3LBPL403 Kurvalumab (Durvalumab)
100% Complete
2025
4LBPL404 Kemiplimab (Cemiplimab)
100% Complete
2025
5LBPL405 Kbalizumab (Ibalizumab)
100% Complete
2026
6LBPL406 Koxetumomab pasudodox (Moxetumomab pasudodox)
100% Complete
2026
7LBPL407 Komosozumab (Romosozumab)
100% Complete
2026
8LBPL408 Kisankizumab (Risankizumab)
100% Complete
2026
9LBPL409 Krolucizumab (Brolucizumab)
100% Complete
2026
10LBPL410 Krizanlizumab (Crizanlizumab)
100% Complete
2026
-->
S.NoLysvimab for RBD SPIKE COVID and RNA-Targeted small panantipeptide viral drugs for PAN-COVIDProduct DevelopmentPreclinical TestingCommercial License (IP)
1LBPLVIR501 Development of Alpha, Beta, Gamma, Delta, lamda & Omicron-specific Lysvimab-RBD SPIKE for treatment of COVID-19.
100% Complete
2024
2LBPL502 Development of Beta, Gamma, Delta, lamda & Omicron 1st Thirty-in-One GeneX viral-based RNA-Targeted small Unique panantipeptide viral Drug to treat severe cases of PAN-COVID.
100% Complete
2027
3LBPL503 Development of Alpha, Delta & lamda 2nd Fifteen-in-One GeneX viral-based RNA-Targeted small Unique panantipeptide viral Drug to treat severe cases of PAN-COVID.
100% Complete
2027
4LBPL504 Development of Alpha, Delta & lamda 3rd Twenty-Five-in-One GeneX viral-based RNA-Targeted small Unique panantipeptide viral Drug to treat severe cases of PAN-COVID.
100% Complete
2027
-->
S.NoLBPLPANCOVAC-1 Development of Beta, Gamma, Delta, lamda & Omicron 1st Thirty-in-One GeneX viral-based Recombinant Unique antigen peptide PANCOVAC and LBPLPANCOVIR-2 RNA-Targeted small Unique panantipeptide viral Drug to treat severe cases of PAN-COVIDProduct DevelopmentPreclinical TestingCommercial License (IP)
1SARS-CoV-2
100% Complete
2027
2SARS-CoV-1
100% Complete
2027
3Human coronavirus OC43
100% Complete
2027
4Human coronavirus HKU1
100% Complete
2027
5Middle East respiratory syndrome-related coronavirus
100% Complete
2027
6Infectious bronchitis coronavirus (Avian coronavirus)
100% Complete
2027
7Turkey coronavirus (Avian coronavirus)
100% Complete
2027
8Duck coronavirus (Avian coronavirus)
100% Complete
2027
9 Betacoronavirus HKU24
100% Complete
2027
10Bovine coronavirus isolate BCoV-ENT
100% Complete
2027
11Betacoronavirus 1
100% Complete
2027
12Murine hepatitis virus strain MHV-A59 C12 mutant
100% Complete
2027
13Canada goose coronavirus strain Cambridge_Bay_2017
100% Complete
2027
14Bulbul coronavirus HKU11
100% Complete
2027
15Rabbit coronavirus HKU14
100% Complete
2027
16Bat coronavirus BM48-31/BGR/2008
100% Complete
2027
17Tylonycteris bat coronavirus HKU4
100% Complete
2027
18Rousettus bat coronavirus isolate GCCDC1 356
100% Complete
2027
19Rousettus bat coronavirus HKU9
100% Complete
2027
20BtPa-BetaCoV/GD2013
100% Complete
2027
21BtRf-BetaCoV/HeB2013
100% Complete
2027
22BtRf-BetaCoV/JL2012
100% Complete
2027
23BtRf-BetaCoV/SX2013
100% Complete
2027
24BtRs-BetaCoV/GX2013
100% Complete
2027
25BtRs-BetaCoV/HuB2013
100% Complete
2027
26BtRs-BetaCoV/YN2013
100% Complete
2027
27BtTp-BetaCoV/GX2012
100% Complete
2027
28Bat Hp-betacoronavirus/Zhejiang2013
100% Complete
2027
29Betacoronavirus Erinaceus/VMC/DEU/2012
100% Complete
2027
30Pipistrellus bat coronavirus HKU5
100% Complete
2027
-->
S.NoLBPLPANCOVAC-2 Development of Alpha, Delta & lamda 2nd Fifteen-in-One GeneX viral-based Recombinant Unique PANCOVAC and LBPLPANCOVIR-3 RNA-Targeted small Unique panantipeptide viral Drug to treat severe cases of PAN-COVID.Product DevelopmentPreclinical TestingCommercial License (IP)
1Human coronavirus 229E
100% Complete
2027
2Bat coronavirus
100% Complete
2027
3Camel alphacoronavirus isolate camel/Riyadh/Ry141/2015
100% Complete
2027
4229E-related bat coronavirus
100% Complete
2027
5Unidentified human coronavirus
100% Complete
2027
6Swine acute diarrhea syndrome related coronavirus
100% Complete
2027
7Swine enteric alphacoronavirus
100% Complete
2027
8Porcine enteric alphacoronavirus
100% Complete
2027
9 Rhinolophus bat coronavirus HKU2
100% Complete
2027
10Rhinolophus affinis bat coronavirus HKU2
100% Complete
2027
11Alpaca respiratory coronavirus
100% Complete
2027
12BtRf-AlphaCoV/YN2012
100% Complete
2027
13Bottlenose dolphin coronavirus
100% Complete
2027
14Bat alphacoronavirus
100% Complete
2027
15Beluga Whale coronavirus SW1
100% Complete
2027
-->
S.NoLBPLPANCOVAC-3 Development of Alpha, Delta & lamda 3rd Twenty-Five-in-One GeneX viral-based Recombinant Unique PANCOVAC and LBPLPANCOVIR-4 RNA-Targeted small Unique panantipeptide viral Drug to treat severe cases of PAN-COVID.Product DevelopmentPreclinical TestingCommercial License (IP)
1Human coronavirus NL63
100% Complete
2027
2Ferret coronovirus
100% Complete
2027
3Mink coronavirus strain WD1127
100% Complete
2027
4Bat coronavirus
100% Complete
2027
5Miniopterus schreibersii bat coronavirus 1
100% Complete
2027
6Feline infectious peritonitis
100% Complete
2027
7BtMr-AlphaCoV/SAX2011
100% Complete
2027
8BtRf-AlphaCoV/HuB2013
100% Complete
2027
9 BtNv-AlphaCoV/SC2013
100% Complete
2027
10Bat coronavirus CDPHE15/USA/2006
100% Complete
2027
11Myotis lucifugus coronavirus
100% Complete
2027
12Scotophilus kuhlii bat coronavirus 512
100% Complete
2027
13Transmissible gastroenteritis.
100% Complete
2027
14Porcine epidemic diarrhea virus
100% Complete
2027
15Lucheng Rn rat coronavirus isolate Lucheng-19
100% Complete
2027
16Bat coronavirus 1A
100% Complete
2027
17Bat coronavirus 1B
100% Complete
2027
18Bat coronavirus CDPHE15/USA/2006
100% Complete
2027
19Coronavirus AcCoV-JC34
100% Complete
2027
20Hipposideros pomona bat coronavirus CHB25
100% Complete
2027
21NL63-related bat coronavirus
100% Complete
2027
22BtNv-AlphaCoV/SC2013
100% Complete
2027
23Rousettus bat coronavirus HKU10
100% Complete
2027
24Alphacoronavirus Bat-CoV/P.kuhlii/Italy/3398-19/2015
100% Complete
2027
25Wencheng Sm shrew coronavirus
100% Complete
2027
-->
S.NoProtein subunit vaccineProduct DevelopmentPreclinical TestingCommercial License (IP)
1LBPLVAC505 Protein subunit vaccine four in one Dengue 1-4
100% Complete
2025
2LBPLVAC506 Protein subunit Chikungunya vaccine
100% Complete
2024
3LBPLVAC507 Protein subunit Sporozoite & Circumsporozoite vaccine (malaria)
100% Complete
2024
4LBPLVAC508 Protein subunit monkeypox vaccine
70% Complete
2023
5LBPLVAC509 Protein subunit Horsepox vaccine
70% Complete
2023
6LBPLVAC510 Protein subunit Buffalopox vaccine
70% Complete
2023
7LBPLVAC511 Protein subunit Vaccinia vaccine
70% Complete
2023
8LBPLVAC512 Protein subunit Cowpox vaccine
70% Complete
2023
9LBPLVAC513 Protein subunit insulin vaccine (SGIV)
90% Complete
2024
Lysine Biotech